Observational analysis reveals similar PROMs achievement in HF and non-HF patients after THA, highlighting healthcare utilization differences.
Given improved treatments and prolonged life expectancy, the number of patients who have heart failure (HF) and undergo total hip arthroplasty (THA) will likely increase; however, few studies evaluate patient-reported outcome measures (PROMs) after THA among these patients. This study aimed to 1) compare achievement of clinically relevant PROM thresholds after THA between HF patients and patients who do not have HF, and 2) report healthcare utilization after THA among these patient cohorts and HF patients who have various ejection fraction percentages (EF%). A prospective cohort of 10,590 primary THA patients at a tertiary center was included. A total of 372 patients had HF and were categorized by EF%: preserved (≥ 50%), mildly reduced (41 to 49%), and reduced (≤ 40%). The PROMs included the Hip Injury and Osteoarthritis Outcome Score for Pain (HOOS-Pain), Physical Function (HOOS-PS), and Joint Replacement (HOOS-JR) with minimal clinically important differences (MCIDs) and patient-acceptable symptomatic state (PASS) thresholds. Healthcare utilization outcomes included prolonged length of stay (LOS), non-home discharge disposition (DD), mortality within one year, and others. A multivariable linear regression modeled predictors of PROMs and utilization outcomes. All tests were two-sided, with a significance level of 0.05. Despite lower median PROMs among HF patients at one year, similar proportions of patients who have and do not have HF achieved HOOS MCIDs. However, greater proportions of HF patients failed to achieve PASS thresholds for HOOS-Pain (P = 0.006), HOOS-PS (P = 0.003), and HOOS-JR (P = 0.005). Also, greater proportions of HF patients experienced LOS (P < 0.001), DD (P < 0.001), and mortality within one year (P < 0.001). Heart failure, but not EF%, was a significant predictor of LOS (P < 0.001), DD (P = 0.003), and 1-year mortality (P = 0.008). Despite lower PROMs and increased utilization, HF patients, like non-HF patients, can expect perceived improvements in pain and function after THA. While HF predicted healthcare utilization, EF% was not associated with these outcomes.
No takes yet. Share an insight, caveat, or question.
Huffman et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: